Tag - biontech

 
Menu
Search
 
April 20, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

BIONTECH

Japan Times
WORLD / Science & Health
Dec 10, 2020
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
Japan Times
WORLD
Dec 6, 2020
With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout
Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.
Japan Times
OLYMPICS
Dec 3, 2020
Tokyo Olympics to require COVID-19 testing of athletes every 120 hours
Organizers plan to require athletes competing at the postponed games next summer to undergo testing every four to five days, even if they do not show symptoms.
Japan Times
WORLD / Science & Health
Dec 3, 2020
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
Japan Times
COMMENTARY / World
Dec 1, 2020
A triumph of German innovation and immigration
The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.
Japan Times
WORLD / Science & Health
Nov 29, 2020
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
COMMENTARY / World
Nov 15, 2020
Here’s to the immigrant heroes behind the BioNTech vaccine
Their journey as Turkish Germans cannot have been easy. Discrimination, overt or subtle, is rife in German society.
Japan Times
COMMENTARY / World
Nov 13, 2020
What happens to the other COVID-19 vaccines now?
If the vaccine created by Pfizer and partner BioNTech fails to live up to its promise, will any slower but better competitors have a chance?
Japan Times
WORLD / Science & Health
Sep 16, 2020
Pfizer COVID-19 vaccine trial reports no major safety issues
Safety has been a paramount concern since AstraZeneca paused tests of the vaccine it's co-developing with the University of Oxford following an adverse event in a U.K.
Japan Times
JAPAN / Science & Health
Aug 7, 2020
Japan and AstraZeneca set for deal on 100 million doses of virus vaccine
The drugmaker is expected to begin clinical trials in Japan later this month to confirm the efficacy and safety of its vaccine, currently being tested overseas.
Japan Times
JAPAN / Science & Health
Aug 1, 2020
Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people
The agreement marks Japan's first advance deal for a vaccine to fight the coronavirus.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
No link to Nankai Trough quake seen after temblor in Shikoku
Satoshi Harada from the Meteorological Agency explains about the magnitude 6.6 earthquake during a news conference early Thursday.
Tehran signals no retaliation against Israel after drones attack Iran
A reported strike against Iran by Israel on Friday came against the backdrop of Iran's support for the Palestinian Hamas militant group, whose assault into Israel on Oct. 7 triggered Israel's invasion of Gaza.
In a first, Japan doctors sue Google over negative reviews on firm's map app
One of the lawyers representing a group of doctors suing Google told a news conference that the main purpose of the lawsuit is not to seek compensation but instead to raise awareness over various problems with the Google Maps system.
Former No. 1 Kento Momota retires from international badminton at 29
Badminton star Kento Momota leaves a news conference after announcing his retirement from Japan's national team, in Tokyo on Thursday.
Thousands evacuated as Indonesia volcano erupts
Indonesia's Mount Ruang spews hot lava and smoke as seen from Sitaro, North Sulawesi, on Wednesday.
'House of the Owl' brings Hollywood values to Japanese TV
In the new Disney+ series “House of the Owl,” Min Tanaka (left) plays a powerful political fixer, or “kuromaku,” who has a troubled relationship with his adult children, particularly his idealistic son, played by Mackenyu.
Benefits and risks: AUKUS looks to take gamble on Japan
U.S. President Joe Biden, Australian Prime Minister Anthony Albanese and British leader Rishi Sunak deliver remarks on the AUKUS partnership, after a trilateral meeting, at Naval Base Point Loma in San Diego in March last year.
Kyoto’s demon night parade lives to haunt another day
In a Kyoto long past, the "hyakki yagyō" (100 demon night parade) haunted a sleepy corner of Kyoto. Now, one enterprising monster enthusiast has won a small batttle to keep the march alive.
U.S. deploys midrange missile system in Indo-Pacific for first time
A U.S. Army Mid-Range Capability (MRC) Launcher arrives as part of the capability’s first deployment into theater on Northern Luzon, Philippines, April 8.
Unpacking the chaotic by-election in a scandal-hit Tokyo district
People listen to a campaign speech in Tokyo's Koto Ward on Tuesday.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Historically, kabuki was considered the entertainment of the merchant and peasant classes, a far cry from how it is regarded today.
For Japan's oldest kabuki theater, the show must go on
By Lance Henderstein

SUSTAINABLE JAPAN

Students ‘study abroad’ on island of Suo Oshima
Students ‘study abroad’ on island of Suo Oshima

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER